NCT00004804View on ClinicalTrials.gov

Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis C

PHASE3CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

August 31, 1993

Conditions
Hepatitis C
Interventions
DRUG

interferon alfa

All Listed Sponsors
collaborator

Tulane University School of Medicine

OTHER

lead

National Center for Research Resources (NCRR)

NIH